Back to top

marijuana: Archive

Sundeep Ganoria

Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?

While CRBP's pipeline shows promise, the company's lack of marketed products remains a concern.

SNYNegative Net Change NVONegative Net Change CRBPNegative Net Change

Sundeep Ganoria

Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold?

TLRY's pivot into beverages shows promise, but with falling cannabis sales and delisting risks, we recommend staying on the sidelines for now.

PMNegative Net Change JAZZPositive Net Change CRBPNegative Net Change TLRYPositive Net Change

Zacks Equity Research

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook

Jazz reports dismal first-quarter results. The company revises its 2025 EPS guidance to account for the recently completed Chimerix acquisition.

JAZZPositive Net Change PBYINegative Net Change NTLAPositive Net Change ELEVPositive Net Change

Zacks Equity Research

IIPR's Q1 Earnings Coming Up: Key Factors to Impact the Stock

IIPR's Q1 2025 results may be impacted by property repossessions/sales, rent deferrals and partial tenant payments.

IIPRPositive Net Change LAMRNegative Net Change EPRNegative Net Change

Sundeep Ganoria

Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings

Investors will likely focus on the sales performance of Jazz Pharmaceuticals' key neuroscience drugs, Xywav and Rylaze, when it reports Q1 results next week.

JAZZPositive Net Change AMRXNegative Net Change

Sundeep Ganoria

3 Unconventional Cannabis Stocks to Watch in 2025

Think cannabis investing is all hype? These three unconventional stocks could change your mind - and your portfolio - in 2025.

PMNegative Net Change JAZZPositive Net Change CRBPNegative Net Change

Sundeep Ganoria

Cardiol Therapeutics Stock: Is Cannabis Potential Priced In?

Cardiol Therapeutics shows promise with its CBD-based heart therapy, but a lack of approved drugs and a narrow pipeline raise red flags for cautious investors.

JAZZPositive Net Change KNSANegative Net Change CRDLNegative Net Change

Sundeep Ganoria

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Both JAZZ and HRMY expect sales from neuroscience products to grow in 2025.

JAZZPositive Net Change HRMYNegative Net Change

Sundeep Ganoria

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Not your typical cannabis play. Discover why Jazz Pharma's FDA-approved CBD drug could make it a top cannabis stock to watch in 2025.

JAZZPositive Net Change TLRYPositive Net Change

Sweta Killa

Best & Worst ETF Zones of Q1

We have highlighted three ETFs, each from the best and worst-performing zones in the first quarter of 2025.

EPOLNegative Net Change SGDMPositive Net Change WGMIPositive Net Change WEEDNegative Net Change EETHPositive Net Change BABONegative Net Change

Urmimala Biswas

Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.

CGCPositive Net Change ACBPositive Net Change OGINo Net Change

Zacks Equity Research

IIPR's Q4 Earnings Coming Up: Key Factors to Impact the Stock

Innovative Industrial's Q4 performance is likely to have been affected by a decline in contractual rent and property management fees and elevated expenses.

RHPNegative Net Change IIPRPositive Net Change PKNegative Net Change

Moumita C. Chattopadhyay

Is IIPR Stock a Buy, Hold or Sell After Its 49% Plunge in 3 Months?

With a volatile cannabis market and tenant risks, is IIPR's high yield sustainable, or will challenges overshadow its growth?

PLDNegative Net Change TRNONegative Net Change IIPRPositive Net Change

Sweta Killa

Top & Flop ETFs of 2024

We have highlighted three ETFs each from the best and worst-performing zones in 2024.

TSLAPositive Net Change ARGTNegative Net Change GBTCPositive Net Change MAGSPositive Net Change BDRYNegative Net Change WEEDNegative Net Change ILITNegative Net Change

Mark Vickery

Markets Up Ahead of CPI, Jobless Claims Thursday

The Inflation Rate, which is CPI year over year headline, is expected to come down 20 basis points from +2.5% to +2.3%.

DALPositive Net Change AANegative Net Change DPZNegative Net Change TLRYPositive Net Change

Sweta Killa

Best and Worst ETF Zones of Q2

Technology remained the best-performing sector of the second quarter on the AI drive while energy lagged.

SLVPNegative Net Change UNGNegative Net Change BDRYNegative Net Change PSILNegative Net Change WGMIPositive Net Change WEEDNegative Net Change

Zacks Equity Research

Innovative Industrial (IIPR) Expands With Florida Asset

Innovative Industrial's (IIPR) Florida property buyout and tie-up with a subsidiary of AYR Wellness are to help this REIT bank on solid opportunities in the company's markets.

AMTNegative Net Change LAMRNegative Net Change IIPRPositive Net Change

Zacks Equity Research

Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings

Cresco Labs' (CRLBF) rationalization and optimization efforts are expected to have had a positive impact on the company's first-quarter margins, profitability and cash flow.

ALCNegative Net Change GRTSNo Net Change ERASNegative Net Change CRLBFNegative Net Change

Sweta Killa

Best and Worst ETF Zones of Q1

Bitcoin and the related stocks were the hottest throughout the first quarter amid growing optimism about the tokens.

SMHPositive Net Change PBWNegative Net Change GBTCPositive Net Change UNGNegative Net Change WEEDNegative Net Change LITPNegative Net Change

Sweta Killa

5 Sector ETFs That Beat the Market in March

The month of March has been good for the U.S. stock market, with the three major bourses on track for the fifth consecutive month of gain.

SLVPNegative Net Change GOAUPositive Net Change MJNegative Net Change CRPTNegative Net Change COPJPositive Net Change

Sweta Killa

5 Market-Beating Sector ETFs of Q1

Wall Street is set to wrap up the first quarter with strong gains. The gains were broad-based and well spread out across various segments.

SMHPositive Net Change CNCRPositive Net Change KBWPNegative Net Change CRPTNegative Net Change WEEDNegative Net Change

Sanghamitra Saha

Is Rescheduling a Certainty for Cannabis? ETFs That Surge

In a White House meeting, Vice President Kamala Harris this week urged the DEA to expedite the rescheduling of marijuana. President Biden also lately talked about ongoing efforts to review the federal classification of marijuana, hinting at his commitment to potential reforms

MJNegative Net Change YOLONegative Net Change CNBSNegative Net Change MSOSPositive Net Change WEEDNegative Net Change

Sweta Killa

Cannabis ETFs Jump on Imminent Rescheduling News

Cannabis stocks & ETFs jumped on Mar 15 after a prominent hedge fund manager suggested that regulators will soon reclassify marijuana as a less dangerous drug.

MJNegative Net Change CNBSNegative Net Change MSOSPositive Net Change WEEDNegative Net Change

Sanghamitra Saha

Marijuana ETFs Breezing Past S&P 500: More Growth Ahead?

Cannabis stocks soared this year after the Department of Health and Human Services asked the US Drug Enforcement Administration to start reviewing its classification of cannabis from Schedule I to Schedule III. Positive developments are happening in Germany also.

MSOSPositive Net Change WEEDNegative Net Change

Sweta Killa

5 Best Leveraged ETFs of First Half of Q1

We highlight a bunch of the best-performing leveraged equity ETFs from different corners of the market that are leaders in their segments in the first half of Q1.

SOXLPositive Net Change USDNegative Net Change PILLNegative Net Change FNGUPositive Net Change MSOXPositive Net Change